Risk of arrhythmia in post-resuscitative shock after out-of-hospital cardiac arrest with epinephrine versus norepinephrine.

Cardiogenic shock Critical care Epinephrine Norepinephrine Out-of-hospital cardiac arrest Vasopressors

Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
10 Dec 2023
Historique:
received: 18 07 2023
revised: 09 11 2023
accepted: 02 12 2023
medline: 17 12 2023
pubmed: 17 12 2023
entrez: 17 12 2023
Statut: aheadofprint

Résumé

To determine the rates of clinically significant tachyarrhythmias and mortality in the management of post-resuscitative shock after return of spontaneous circulation (ROSC) in patients with out-of-hospital cardiac arrest (OHCA) who receive a continuous epinephrine versus norepinephrine infusion. Retrospective cohort study. A large multi-site health system with hospitals across the United States. Adult patients admitted for OHCA with post-resuscitative shock managed with either epinephrine or norepinephrine infusions within 6 h of ROSC. None. Between May 5 There was no statistically significant difference in clinically significant cardiac tachyarrhythmias in post-OHCA patients treated with epinephrine versus norepinephrine infusions after ROSC. Re-arrest rates and in-hospital mortality were higher in patients who received epinephrine infusions in the first 6 h post-ROSC. Results of this study add to the literature suggesting norepinephrine may be the vasopressor of choice in post-OHCA patients with post-resuscitative shock after ROSC.

Identifiants

pubmed: 38104386
pii: S0735-6757(23)00681-2
doi: 10.1016/j.ajem.2023.12.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-76

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors have disclosed that they do not have any potential conflicts of interest.

Auteurs

Sarah Normand (S)

Department of Pharmacy, Mayo Clinic Health System, Eau Claire, WI, USA. Electronic address: normand.sarah@mayo.edu.

Courtney Matthews (C)

Department of Pharmacy, Mayo Clinic Health System, Eau Claire, WI, USA.

Caitlin S Brown (CS)

Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.

Alicia E Mattson (AE)

Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.

Kristin C Mara (KC)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.

Fernanda Bellolio (F)

Department of Emergency Medicine, Mayo Clinic, Rochester, MN, USA.

Erin D Wieruszewski (ED)

Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.

Classifications MeSH